← All Sponsors
SPONSOR

Sumitomo Pharma Switzerland GmbH

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Uterine FibroidsEndometriosis
NCT05862272 Phase 3
Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Uterine Fibroids
United States View Trial →